Maurici D - Search Results

1

The tumor suppressor gene TP53: implications for cancer management and therapy.

Seemann S, Maurici D, Olivier M, Caron de Fromentel C, Hainaut P. Seemann S, et al. Among authors: maurici d. Crit Rev Clin Lab Sci. 2004;41(5-6):551-83. doi: 10.1080/10408360490504952. Crit Rev Clin Lab Sci. 2004. PMID: 15603511 Review.

2

Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1.

North S, Pluquet O, Maurici D, El-Ghissassi F, Hainaut P. North S, et al. Among authors: maurici d. Mol Carcinog. 2002 Mar;33(3):181-8. doi: 10.1002/mc.10038. Mol Carcinog. 2002. PMID: 11870884

3

Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay.

Maurici D, Monti P, Campomenosi P, North S, Frebourg T, Fronza G, Hainaut P. Maurici D, et al. Oncogene. 2001 Jun 14;20(27):3533-40. doi: 10.1038/sj.onc.1204428. Oncogene. 2001. PMID: 11429700

4

Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.

Fulci G, Ishii N, Maurici D, Gernert KM, Hainaut P, Kaur B, Van Meir EG. Fulci G, et al. Among authors: maurici d. Cancer Res. 2002 May 15;62(10):2897-905. Cancer Res. 2002. PMID: 12019170

5

Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia.

Tanière P, Martel-Planche G, Maurici D, Lombard-Bohas C, Scoazec JY, Montesano R, Berger F, Hainaut P. Tanière P, et al. Among authors: maurici d. Am J Pathol. 2001 Jan;158(1):33-40. doi: 10.1016/S0002-9440(10)63941-7. Am J Pathol. 2001. PMID: 11141476 Free PMC article.

6

Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma.

Serra M, Maurici D, Scotlandi K, Barbanti-Brodano G, Manara MC, Benini S, Picci P, Bertoni F, Bacci G, Sottili S, Baldini N. Serra M, et al. Among authors: maurici d. Int J Oncol. 1999 Feb;14(2):301-7. doi: 10.3892/ijo.14.2.301. Int J Oncol. 1999. PMID: 9917506

7

The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells.

Scotlandi K, Manara MC, Serra M, Benini S, Maurici D, Caputo A, De Giovanni C, Lollini PL, Nanni P, Picci P, Campanacci M, Baldini N. Scotlandi K, et al. Among authors: maurici d. Oncogene. 1999 Jan 21;18(3):739-46. doi: 10.1038/sj.onc.1202330. Oncogene. 1999. PMID: 9989824

8

Adriamycin binding assay: a valuable chemosensitivity test in human osteosarcoma.

Baldini N, Scotlandi K, Serra M, Kusuzaki K, Shikita T, Manara MC, Maurici D, Campanacci M. Baldini N, et al. Among authors: maurici d. J Cancer Res Clin Oncol. 1992;119(2):121-6. doi: 10.1007/BF01209668. J Cancer Res Clin Oncol. 1992. PMID: 1358894

9

Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome.

Baldini N, Scotlandi K, Barbanti-Bròdano G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S, Campanacci M, et al. Baldini N, et al. Among authors: maurici d. N Engl J Med. 1995 Nov 23;333(21):1380-5. doi: 10.1056/NEJM199511233332103. N Engl J Med. 1995. PMID: 7477118 Free article.

10

Clinical relevance of Ki-67 expression in bone tumors.

Scotlandi K, Serra M, Manara MC, Maurici D, Benini S, Nini G, Campanacci M, Baldini N. Scotlandi K, et al. Among authors: maurici d. Cancer. 1995 Feb 1;75(3):806-14. doi: 10.1002/1097-0142(19950201)75:3<806::aid-cncr2820750310>3.0.co;2-s. Cancer. 1995. PMID: 7828130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters